Cancer Center Seminar Series

photo of seminar

About the Seminar Series

Presented by Masonic Cancer Center, University of Minnesota this interdisciplinary seminar series provides a venue for basic-science and clinical researchers to hear about cutting-edge work in all areas of cancer. The series features invited speakers and MCC faculty with expertise in selected topics related to cancer. Speakers in our series represent the research programs of the MCC: Carcinogenesis and Chemoprevention, Cellular Mechanisms, Genetic Mechanisms, Immunology, Screening, Prevention, Etiology and Cancer Survivorship (SPECS), and Transplant Biology & Therapy.

Tuesdays, 9-10 a.m., Seminar Room, First Floor, Cancer and Cardiovascular Research Building (simulcast in 450 MCRB, Hormel Institute room 155, and Duluth, 112-SMed )

Seminar presentations are recorded when possible and available to view on the MCC YouTube page.

For more information: 625-5129,

Upcoming Seminars

Development of engineered T cell therapies for therapeutically targeting pancreatic cancer

January 22, 2019

Ingunn Stromnes, PhD, Assistant Professor, Dept of Microbiology and Immunology, University of Minnesota

Studying healthy and diseased biology with synthetic cells

January 29, 2019

Kate Adamala, PhD, Assistant Professor Genetics, Cell Biology and Development, University of Minnesota

Translating insights from yeast to discover genetic interactions in humans

February 5, 2019

Chad Myers, PhD, Associate Professor Computer Science & Engineering, University of Minnesota

Impact of obesity on immunotherapy: both the good and the bad

February 12, 2019

William Murphy, PhD,  Professor, Dept of Dermatology and Internal Medicine, Divison of Hematology/Oncology, University of California-Davis

Host: Bruce Blazar, MD

Optimizing cervical cancer prevention: Balancing the risks and benefits

February 19, 2019

Deanna Teoh, MD, MS, FACOG, FACS, Assistant Professor, Division of Gynecologic Oncology, University of Minnesota

Novel requirements for human natural killer cell development

February 26, 2019

Emily Mace, PhD, Assistant Professor of Pediatrics, Columbia University

Host: Frank Cichocki, PhD

RET tyrosine kinase in neuroendocrine prostate cancer

March 5, 2019

Justin Drake PhD, Assistant Professor of Pharmacology and Urology, University of Minnesota

Targeting the CD200 Checkpoint Blockade: A New Direction for Immunotherapy

March 12, 2019

Michael Olin, PhD, Assistant Professor, Dept of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota

Oxidative Stress Defenses in Cancer

March 19, 2019

Joan Brugge PhD, Louise Foote Pfeiffer Professor of Cell Biology, Director of the Ludwing Center, Harvard Medical School

Leveraging PTEN nuclear function for therapeutic intervention in glioma

March 26, 2019

Frank Furnari, PhD, Member and Head, Laboratory of Tumor Biology, Ludwig Institute for Cancer Research, Professor-Department of Pathology, University of California-San Diego


April 2, 2019